LianBio (LIAN) Competitors $0.20 +0.01 (+4.06%) As of 02/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFinancialsInsider TradesSEC FilingsTrends LIAN vs. TLSA, ANL, VTGN, CLSD, THTX, ASRT, GNTA, PYRGF, IMAB, and PYXSShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include Tiziana Life Sciences (TLSA), Adlai Nortye (ANL), Vistagen Therapeutics (VTGN), Clearside Biomedical (CLSD), Theratechnologies (THTX), Assertio (ASRT), Genenta Science (GNTA), PyroGenesis Canada (PYRGF), I-Mab (IMAB), and Pyxis Oncology (PYXS). These companies are all part of the "pharmaceutical products" industry. LianBio vs. Tiziana Life Sciences Adlai Nortye Vistagen Therapeutics Clearside Biomedical Theratechnologies Assertio Genenta Science PyroGenesis Canada I-Mab Pyxis Oncology Tiziana Life Sciences (NASDAQ:TLSA) and LianBio (NASDAQ:LIAN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings, community ranking and analyst recommendations. Is TLSA or LIAN more profitable? Tiziana Life Sciences' return on equity of 0.00% beat LianBio's return on equity.Company Net Margins Return on Equity Return on Assets Tiziana Life SciencesN/A N/A N/A LianBio N/A -33.17%-30.19% Do institutionals & insiders hold more shares of TLSA or LIAN? 74.8% of LianBio shares are held by institutional investors. 39.8% of Tiziana Life Sciences shares are held by company insiders. Comparatively, 7.6% of LianBio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer TLSA or LIAN? In the previous week, Tiziana Life Sciences had 4 more articles in the media than LianBio. MarketBeat recorded 5 mentions for Tiziana Life Sciences and 1 mentions for LianBio. LianBio's average media sentiment score of 0.75 beat Tiziana Life Sciences' score of 0.40 indicating that LianBio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tiziana Life Sciences 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LianBio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in TLSA or LIAN? Tiziana Life Sciences received 92 more outperform votes than LianBio when rated by MarketBeat users. Likewise, 63.58% of users gave Tiziana Life Sciences an outperform vote while only 36.36% of users gave LianBio an outperform vote. CompanyUnderperformOutperformTiziana Life SciencesOutperform Votes9663.58% Underperform Votes5536.42% LianBioOutperform Votes436.36% Underperform Votes763.64% Which has higher valuation and earnings, TLSA or LIAN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTiziana Life SciencesN/AN/A-$17.69MN/AN/ALianBioN/AN/A-$110.29M-$0.81-0.25 Which has more volatility and risk, TLSA or LIAN? Tiziana Life Sciences has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, LianBio has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. SummaryTiziana Life Sciences beats LianBio on 8 of the 10 factors compared between the two stocks. Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.15M$117.96M$5.77B$8.99BDividend YieldN/A3.69%4.78%3.85%P/E Ratio-0.253.2026.4618.82Price / SalesN/A4,828.14453.6978.73Price / CashN/A13.0144.0437.47Price / Book0.0847.077.634.64Net Income-$110.29M-$87.82M$3.18B$245.69M7 Day Performance6.05%0.36%-1.91%-2.66%1 Month Performance-12.36%3.63%-0.19%-2.15%1 Year Performance-95.72%99.12%16.70%12.90% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBioN/A$0.21+4.1%N/A-95.7%$22.15MN/A-0.25110News CoverageTLSATiziana Life Sciences0.78 of 5 stars$0.79+7.0%N/A+56.1%$83.48MN/A0.008ANLAdlai Nortye2.111 of 5 stars$2.25-2.2%$9.00+300.0%-70.8%$83.03M$5M0.00127High Trading VolumeVTGNVistagen Therapeutics0.9076 of 5 stars$2.97+4.2%N/A-39.1%$82.69M$1.06M-2.4040CLSDClearside Biomedical2.0843 of 5 stars$1.07+5.9%$5.33+398.4%-26.9%$81.15M$8.23M-2.3830THTXTheratechnologiesN/A$1.75+7.4%N/A+8.5%$80.47M$81.76M-17.50140Gap UpHigh Trading VolumeASRTAssertio2.9977 of 5 stars$0.84-1.6%$3.25+286.2%+3.0%$80.36M$152.07M-1.1520Short Interest ↓Positive NewsGNTAGenenta Science2.6269 of 5 stars$4.37+14.4%$25.00+472.1%-10.0%$79.93MN/A0.007Gap UpPYRGFPyroGenesis CanadaN/A$0.43-4.8%N/A+21.0%$79.36M$9.14M-7.1890Gap DownIMABI-Mab3.4044 of 5 stars$0.96+1.5%$8.00+730.0%-38.9%$78.55M$3.89M0.00380News CoveragePYXSPyxis Oncology2.0865 of 5 stars$1.32+1.5%$9.20+597.0%-71.6%$78.50M$16.15M-1.2860 Related Companies and Tools Related Companies TLSA Alternatives ANL Alternatives VTGN Alternatives CLSD Alternatives THTX Alternatives ASRT Alternatives GNTA Alternatives PYRGF Alternatives IMAB Alternatives PYXS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIAN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
